Waukesha, WI — August 4, 2014 — Today GE Healthcare announced that the first integrated, simultaneous, time-of-flight (TOF) capable, whole body SIGNA PET/MR* is 510(k) pending at the FDA. Powered by simultaneous image acquisition from GE’s latest 3.0 Tesla magnetic resonance (MR) technology and innovative positron emission tomography (PET) technology, the SIGNA PET/MR represents a new chapter in helping clinicians achieve improved scan efficiency that may lead to more effective treatment paths for clinicians to offer their patients, particularly for oncology, neurology, and cardiology.

SAN ANTONIO, July 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The patent US 8,772,226 B2 was issued July 8, 2014.

PRINCETON, N.J.--(BUSINESS WIRE)--Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.

In an article published in the ICD10 monitor, Shannon DeConda, the founder and president of the National Alliance of Medical Auditing Specialists, compares the financial burdens brought on by EHR and ICD-10. In preparation for the ICD-10 implementation, hospital systems and larger health care facilities have large budgets planned for 2015, and many have already invested a significant outlay of money in education and training to meet the fall 2014 deadline. There also is the risk that unpracticed ICD-10 coding skills could diminish over the next 18 months. 

Look in the mirror, says demographer Faith Popcorn in “Flying into the Future,” five trends to watch in 2014. Popcorn predicts that the line between device and human will vanish as wearable technology becomes implanted, presenting extraordinary opportunities in health care.

June 7-11, 2014St. Louis, MO 

Among the many requirements a hospital must meet to achieve and maintain the designation of Critical Access Hospital (CAH), the hospital must be fairly remote and furnish 24-hour emergency care services seven days a week, using either on-site or on-call staff.

SBRI contract to explore potential of low-cost commercial 3D scanner in healthcare applicationsOxford, UK & Greenville, NC – April 9, 2014 – Fuel 3D Technologies Ltd., developer of 3D scanning solutions, today announced it has secured a £685,831 ($1.1 million) SBRI Healthcare development contract for the development of a 3D medical imaging system. SBRI Healthcare is an NHS England initiative, which aims to promote UK economic growth while addressing unmet health needs and enhancing the take up of known best practice. Fuel 3D Technologies will use the contract to develop its Eykona scanner technology for a range of therapy applications and adoption in the NHS and international healthcare markets.